TY - JOUR
T1 - Physical Health, Media Use, and Mental Health in Children and Adolescents With ADHD During the COVID-19 Pandemic in Australia
AU - Sciberras, Emma
AU - Patel, Pooja
AU - Stokes, Mark A.
AU - Coghill, David
AU - Middeldorp, Christel M.
AU - Bellgrove, Mark A.
AU - Becker, Stephen P.
AU - Efron, Daryl
AU - Stringaris, Argyris
AU - Faraone, Stephen V.
AU - Bellows, Susannah T.
AU - Quach, Jon
AU - Banaschewski, Tobias
AU - McGillivray, Jane
AU - Hutchinson, Delyse
AU - Silk, Tim J.
AU - Melvin, Glenn
AU - Wood, Amanda G.
AU - Jackson, Anna
AU - Loram, George
AU - Engel, Lidia
AU - Montgomery, Alicia
AU - Westrupp, Elizabeth
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding support for this project was provided through the Center for Social and Early Emotional Development, a Strategic Research Center of the Office of the Deputy Vice Chancellor Research, Deakin University Australia. A/Prof Sciberras was funded by an Australian National Health and Medical Research Council Career (NHMRC) Development Fellowship (1110688) and a veski Inspiring Women’s Fellowship. Prof Bellgrove is supported by a Senior Research Fellowship (level B) from the NHMRC. A/Prof Efron was supported by a Clinician Scientist Fellowship from the Murdoch Children’s Research Institute (MCRI). A/Prof Hutchinson was supported by a NHMRC Investigator Grant (1197488). MCRI is supported by the Victorian Government’s Operational Infrastructure Support program.
Funding Information:
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: A/Prof Sciberras receives royalties from her book published through Elsevier: Sleep and ADHD: An Evidence-Based Guide to Assessment and Treatment. In the past 3 years Prof Coghill served in an advisory or consultancy role for Shire/Takeda. He received conference support or speaker’s fee from Medice, Servier and Shire/Takeda. He received royalties from Oxford University Press; the present work is unrelated to these relationships. In the past year, Dr Faraone received income, potential income, travel expenses continuing education support and/or research support from Takeda, OnDosis, Tris, Otsuka, Arbor, Ironshore, Rhodes, Akili Interactive Labs, Enzymotec, Sunovion, Supernus and Genomind. With his institution, he has US patent US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. He also receives royalties from books published by Guilford Press: Straight Talk about Your Child’s Mental Health, Oxford University Press: Schizophrenia: The Facts and Elsevier: ADHD: Non-Pharmacologic Interventions. He is Program Director of www.adhdinadults.com . Prof Banaschewski served in an advisory or consultancy role for Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Shire, and Infectopharm. He received conference support or speaker’s fee by Lilly, Medice, and Shire. He received royalities from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press; the present work is unrelated to these relationships. Prof McGillivray currently receives funding from the Moose Foundation, Victorian Department of Education and Training, MECCA Brands, Wenig Family, and Grace and Emilio Foundation to conduct research into neurodevelopmental disorders and inclusion and from the Victorian Departments of Human Services, Justice and Community Safety to conduct research on resilience in young people in out of home care. She also receives funding from the Ferrero Group Australia as part of its Kinder + Sports pillar of Corporate of Social Responsibility initiatives to promote active lifestyles among young people. None of the companies or organizations listed above had a role in this research including the collection, analysis and interpretation of data; in writing of the manuscript; and/or the decision to submit the article for publication. Dr Becker has received grant funding from the Institute of Education Sciences (IES), U.S. Department of Education; National Institute of Mental Health (NIMH); and Cincinnati Children’s Research Foundation (CCRF), and has received book honoraria from Guilford Press. A/Prof Sciberras, Prof Coghill, Prof Bellgrove, Prof Middeldorp, A/Prof Silk and Dr Montgomery are all on the board of the Australian ADHD Professionals Association (AADPA). Prof Bellgrove is President AADPA, which is leading the development of National Clinical Guidelines for ADHD in Australia.
Publisher Copyright:
© ©The Author(s) 2020.
PY - 2022/2
Y1 - 2022/2
N2 - Objective: To examine the impact of COVID-19 restrictions among children with attention-deficit/hyperactivity disorder (ADHD). Methods: Parents of 213 Australian children (5–17 years) with ADHD completed a survey in May 2020 when COVID-19 restrictions were in place (i.e., requiring citizens to stay at home except for essential reasons). Results: Compared to pre-pandemic, children had less exercise (Odds Ratio (OR) = 0.4; 95% CI 0.3–0.6), less outdoor time (OR = 0.4; 95% 0.3–0.6), and less enjoyment in activities (OR = 6.5; 95% CI 4.0–10.4), while television (OR = 4.0; 95% CI 2.5–6.5), social media (OR = 2.4; 95% CI 1.3–4.5), gaming (OR = 2.0; 95% CI 1.3–3.0), sad/depressed mood (OR = 1.8; 95% CI 1.2–2.8), and loneliness (OR = 3.6; 95% CI 2.3–5.5) were increased. Child stress about COVID-19 restrictions was associated with poorer functioning across most domains. Most parents (64%) reported positive changes for their child including more family time. Conclusions: COVID-19 restrictions were associated with both negative and positive impacts among children with ADHD.
AB - Objective: To examine the impact of COVID-19 restrictions among children with attention-deficit/hyperactivity disorder (ADHD). Methods: Parents of 213 Australian children (5–17 years) with ADHD completed a survey in May 2020 when COVID-19 restrictions were in place (i.e., requiring citizens to stay at home except for essential reasons). Results: Compared to pre-pandemic, children had less exercise (Odds Ratio (OR) = 0.4; 95% CI 0.3–0.6), less outdoor time (OR = 0.4; 95% 0.3–0.6), and less enjoyment in activities (OR = 6.5; 95% CI 4.0–10.4), while television (OR = 4.0; 95% CI 2.5–6.5), social media (OR = 2.4; 95% CI 1.3–4.5), gaming (OR = 2.0; 95% CI 1.3–3.0), sad/depressed mood (OR = 1.8; 95% CI 1.2–2.8), and loneliness (OR = 3.6; 95% CI 2.3–5.5) were increased. Child stress about COVID-19 restrictions was associated with poorer functioning across most domains. Most parents (64%) reported positive changes for their child including more family time. Conclusions: COVID-19 restrictions were associated with both negative and positive impacts among children with ADHD.
KW - ADHD
KW - COVID-19
KW - psychological well-being
UR - http://www.scopus.com/inward/record.url?scp=85097780749&partnerID=8YFLogxK
U2 - 10.1177/1087054720978549
DO - 10.1177/1087054720978549
M3 - Article
C2 - 33331195
AN - SCOPUS:85097780749
SN - 1087-0547
VL - 26
SP - 549
EP - 562
JO - Journal of Attention Disorders
JF - Journal of Attention Disorders
IS - 4
ER -
